Pancreatic Cancer Research

ResearcherNuvox Pharma, LlcNo recent work listed

Juergen Karl Willmann

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 9442280. Sources: NIH RePORTER.

Their work

Papers
0
Trials
0
Grants
2
Labs led
1
Collaborators
2
Papers, trials and grants by year

2016: 1 grant · 2017: 1 grant

Grants 2

  1. High Sensitivity Molecular Ultrasound Imaging in Pancreatic Cancer R21EB022770↗
  2. Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development R41CA203090↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jeremy Dahl · 1 shared grant, 2017 · strength 0.29
  2. Evan charles Unger · 1 shared grant, 2016 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.